ArticleClinicoEconomics and outcomes research : CEOR2025

Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for Induction Chemotherapy and Impact of Oral Formulation Introduction: A Micro-Costing Study in Italy.

Alessandra Di Costanzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.